| パッケージ | 価格 | 錠剤 | 節約 | ご注文 |
|---|---|---|---|---|
| 6mg × 10 tablet | ¥ 0.00 錠剤 ¥ 0.00 | ¥ 0.00 | お買物かごに入れる | |
| 6mg × 20 tablet | ¥ 0.00 錠剤 ¥ 0.00 | ¥ 0.00 | - | お買物かごに入れる |
| 6mg × 30 tablet | ¥ 8732.22 錠剤 ¥ 291.07 | ¥ 291.07 | - | お買物かごに入れる |
| 6mg × 60 tablet | ¥ 10917.10 錠剤 ¥ 181.95 | ¥ 181.95 | - | お買物かごに入れる |
| 6mg × 90 tablet | ¥ 13101.97 錠剤 ¥ 145.58 | ¥ 145.58 | - | お買物かごに入れる |
| 6mg × 120 tablet | ¥ 14558.56 錠剤 ¥ 121.32 | ¥ 121.32 | - | お買物かごに入れる |
| 6mg × 180 tablet | ¥ 18928.31 錠剤 ¥ 105.16 | ¥ 105.16 | - | お買物かごに入れる |
| パッケージ | 価格 | 錠剤 | 節約 | ご注文 |
|---|---|---|---|---|
| 24mg × 12 tablet | ¥ 0.00 錠剤 ¥ 0.00 | ¥ 0.00 | お買物かごに入れる | |
| 24mg × 24 tablet | ¥ 18928.31 錠剤 ¥ 788.68 | ¥ 788.68 | - | お買物かごに入れる |
| 24mg × 36 tablet 無料航空便配送 | ¥ 27667.81 錠剤 ¥ 768.55 | ¥ 768.55 | - | お買物かごに入れる |
| 24mg × 60 tablet 無料航空便配送 | ¥ 43690.24 錠剤 ¥ 728.17 | ¥ 728.17 | - | お買物かごに入れる |
| 24mg × 90 tablet 無料航空便配送 | ¥ 63354.12 錠剤 ¥ 703.93 | ¥ 703.93 | - | お買物かごに入れる |
| 24mg × 120 tablet 無料航空便配送 | ¥ 80104.84 錠剤 ¥ 667.54 | ¥ 667.54 | - | お買物かごに入れる |
| パッケージ | 価格 | 錠剤 | 節約 | ご注文 |
|---|---|---|---|---|
| 30mg × 12 tablet | ¥ 0.00 錠剤 ¥ 0.00 | ¥ 0.00 | お買物かごに入れる | |
| 30mg × 24 tablet 無料航空便配送 | ¥ 23298.06 錠剤 ¥ 970.75 | ¥ 970.75 | - | お買物かごに入れる |
| 30mg × 36 tablet 無料航空便配送 | ¥ 33494.15 錠剤 ¥ 930.39 | ¥ 930.39 | - | お買物かごに入れる |
| 30mg × 60 tablet 無料航空便配送 | ¥ 52429.74 錠剤 ¥ 873.83 | ¥ 873.83 | - | お買物かごに入れる |
| 30mg × 90 tablet 無料航空便配送 | ¥ 72821.92 錠剤 ¥ 809.13 | ¥ 809.13 | - | お買物かごに入れる |
Deflazacort tablets
What is this medicine?
Deflazacort a corticosteroid indicated for the treatment of Duchenne muscular dystrophy (DMD) in patients 5 years of age and older.
What should I tell my health care providers before I take this medicine?
They need to know if you have any of these conditions:
- Hypersensitivity to deflazacort;
- Alterations in Endocrine Function: Hypothalamic-pituitary-adrenal axis suppression, Cushing’s syndrome, and hyperglycemia;
- Immunosuppression and Increased Risk of Infection: Increased risk of new, exacerbation, dissemination, or reactivation of latent infections, which can be severe and at times fatal;
- Alterations in Cardiovascular/Renal Function: elevated blood pressure and sodium, and for decreased potassium level;
- Gastrointestinal Perforation: GI disorders;
- Behavioral and Mood Disturbances: euphoria, insomnia, mood swings, personality changes, severe depression, and psychosis;
- Effects on Bones: decreases in bone mineral density;
- Serious Skin Rashes;
- Ophthalmic Effects: May include cataracts, infections, and glaucoma;
- Vaccination: Do not administer live or live attenuated vaccines to patients receiving immunosuppressive doses of corticosteroids.
How should I use this medicine?
The recommended once-daily dosage is approximately 0.9 mg/kg/day administered orally. Discontinue gradually when administered for more than a few day..
What may interact with this medicine?
- Moderate or strong CYP3A4 inhibitors: Give one third of the recommended dosage;
- Avoid use of moderate or strong CYP3A4 inducers, as they may reduce efficacy.
What side effects may I notice from this medicine?
The most common adverse reactions are Cushingoid appearance, weight increased, increased appetite, upper respiratory tract infection, cough, pollakiuria, hirsutism, central obesity, and nasopharyngitis.